PRTODAY / NewswireToday Free press release distribution service network

Written by / Agency / Source: Werbeagentur & PR-Agentur co-operate

Check Ads Availability|e-mail Article


Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!

Merger and New Name – Pharmaceutical Service Provider Diapharm Grows Together - German service providers for the pharmaceutical industry merge, trading under the new name Diapharm
Merger and New Name – Pharmaceutical Service Provider Diapharm Grows Together

 

NewswireToday - /newswire/ - Muenster, North Rhine-Westfalia, Germany, 2008/01/29 - German service providers for the pharmaceutical industry merge, trading under the new name Diapharm.

   
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma/BioTech/Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

From 1 February 2008 the Diapharm group of companies will operate under a new structure, with Diapharm International GmbH handling all the pharmaceutical service provider’s central customer management services. The specialist regulatory consultancy companies, Dr. Stefan Sandner GmbH in Münster and Dr. Kolkmann & Partner GmbH in Oldenburg, are merging to form Diapharm Regulatory Services GmbH. Both companies will keep their own premises. Starting in February, the group’s companies in Oldenburg and Lübeck specializing in clinical & user testing, biotechnology and analysis will also be trading under the single name Diapharm.

“We are changing to this more centralized corporate structure in response to our customers’ needs: areas of expertise are arranged more clearly and lines of communication are more transparent”, explains Dr. Stefan Sandner, Managing Director of Diapharm International GmbH. The core of the group is the specialist agency diapharm® which was founded in 1988. In 2007 the DiapharmGruppe companies achieved sales of more than 10 million euros.

Advice and service for medicinal and health products

Diapharm assists companies in the medicinal and health-product industries with all regulatory, medical and pharmaceutical matters relating to medicinal products, medical devices, food supplements, biocides and cosmetics. In addition to the headquarters, Diapharm International GmbH, Diapharm also consists of Diapharm Clinical Management GmbH in Oldenburg (formerly Beate Beime & Team), Diapharm Biotech GmbH in Lübeck (formerly Dr. Middeler et al. GmbH), Diapharm Analytics GmbH in Oldenburg (formerly Zentralinstitut Arzneimittelforschung GmbH) and Diapharm Regulatory Services GmbH (formerly Dr. Stefan Sandner GmbH and Dr. Kolkmann & Partner GmbH) in Oldenburg and Münster.

Dr. Ebeling & Assoc. GmbH in Hamburg and Hälsa Pharma GmbH in Lübeck will continue to be partners of Diapharm. The group is represented Europe-wide, with partners in France, the United Kingdom, Poland, Portugal, Slovenia, Spain, the Czech Republic and Hungary.

 
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma/BioTech/Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Written by / Agency / Source: Werbeagentur & PR-Agentur co-operate

 
 

Availability: All Regions (Including Int'l)

 

Traffic Booster: [/] Quick Newswire Today Visibility Checker

 

Distribution / Indexing: [+]

 
 
# # #
 

 
  Your Banner Ad showing on ALL
Pharma/BioTech/Nutrition articles,
CATCH Visitors via Your Competitors Announcements!


Merger and New Name – Pharmaceutical Service Provider Diapharm Grows Together

Company website links NOT available to basic submissions
It is OK to republish and/or LINK any newswire for any legitimate media purpose as long as you name Newswire Today and LINK as the source.
 
  Is this your article?
Activate ALL web links and social stream by Upgrading to Press Release PREMIUM Plan Now!

|
Publisher Contact: Christian Rieke - Co-Operate.net 
 
Newswire Today - PRZOOM / PRTODAY disclaims any content contained in this article. If you need/wish to contact the company who published the current release, you will need to contact them - NOT us. Issuers of articles are solely responsible for the accuracy of their content. Our complete disclaimer appears here.
IMPORTANT INFORMATION: Issuance, publication or distribution of this press release in certain jurisdictions could be subject to restrictions. The recipient of this press release is responsible for using this press release and the information herein in accordance with the applicable rules and regulations in the particular jurisdiction. This press release does not constitute an offer or an offering to acquire or subscribe for any Werbeagentur & PR-Agentur co-operate securities in any jurisdiction including any other companies listed or named in this release.

Pharma/BioTech/Nutrition via RSSAdd NewswireToday - PRZOOM Headline News to FeedBurner
Find who RetweetFollow @NewswireTODAY



Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!


Read Latest Articles From Werbeagentur & PR-Agentur co-operate / Company Profile


Read Pharma/BioTech/Nutrition Most Recent Related Newswires:

Ipsen Announces Phase 3 CELESTIAL Trial of Cabozantinib Meets Primary Endpoint of Overall Survival
First Patient Treated with Microscopic Beads Pre-loaded with A Targeted Cancer Drug and Visible on CT Scans
BTG Plc Acquires Roxwood Medical
BTG and Mirada Medical Sign Three-Year Software Development Agreement
U.S. FDA Approves New Indication for Ipsen’s Somatuline® Depot (lanreotide) Injection for the Treatment of Carcinoid Syndrome
Genentech Provides Update on First Lampalizumab Phase III Study for Geographic Atrophy, an Advanced Form of Age-Related Macular Degeneration
mProve Health and Greenphire Partner to Deliver a First-of-its-Kind Patient Engagement Solution
FDA Approves Genentech’s Actemra (Tocilizumab) for the Treatment of CAR T Cell-Induced Cytokine Release Syndrome
Greenphire Named to Inc. 5000 for Fifth Consecutive Year
Five Community Health Centers Honored for Innovative Approaches to Medication Therapy Management
FDA Grants Priority Review for Genentech’s Gazyva in Previously Untreated Follicular Lymphoma
ProSci Incorporates Flow Cytometry Screening to Custom Monoclonal Antibody Service
FDA Grants Priority Review to Genentech's Emicizumab for Hemophilia A with Inhibitors
BD Expands Suite of Blood Culture Offerings with New BD BACTEC™ Standard Aerobic & Standard Anaerobic Plastic Bottles
Twist Bioscience Collaborates with Synbio Technologies to Supply Long DNA to Customers

Boost Your Social Network
& Crowdfunding Campaigns


LIFETIME SOCIAL MEDIA WALL
NewswireToday Celebrates 10 Years in Business


PREMIUM Members


Visit  JobsWare.com

Visit  La Bella Bakery Artisan Bakery Arizona





 
  ©2017 Newswire Today — Limelon Advertising, Co.
Home | About | Advertise/Pricing | Contact | Investors | Privacy/TOS | Sitemap | FRANCAIS
newswire, PR press releases distribution service magazines engine news alert newsroom press room breaking news public relations articles company news alerts newswiredistribution ezine bizentrepreneur biznewstoday digital business report market search pr firms agencies reports distri-bution today investor relation successful internet entrepreneurs newswire distribution prtoday.com freenewswiredistribution asianewstoday bizwiretoday USA pr UK today - NOT affiliated with PRNewswire as we declined their partnership offer in 2013
 
PRTODAY & NewswireTODAY are NOT affiliated with USA TODAY (usatoday.com)